3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
11
Melanoma
9
Clear-cell metastatic renal cell carcinoma
5
Neoplasm Metastasis
4
Carcinoma, Non-Small-Cell Lung
4
Prostatic Neoplasms
3
Carcinoma, Transitional Cell
3
Carcinoma, Basal Cell
3
Urogenital Neoplasms
2
Urinary Bladder Neoplasms
2
Urethral Neoplasms
2
Thyroid Neoplasms
2
Sarcoma
2
Penile Neoplasms
2
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Myelodysplastic Syndromes
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Histiocytoma, Malignant Fibrous
2
Hematologic Neoplasms
2
Glioblastoma
2
Carcinoma, Merkel Cell
2
Carcinoma, Endometrioid
2
Brain Neoplasms
2
Adenocarcinoma of Lung
2
Xeroderma Pigmentosum
1
Vulvar Neoplasms
1
Uveal Melanoma
1
Interventions
Rituximab
14
Cyclophosphamide
10
Magnetic Resonance Spectroscopy
8
Lenalidomide
8
venetoclax
6
Specimen Handling
6
obinutuzumab
5
ibrutinib
5
Prednisone
5
Biopsy
5
zanubrutinib
4
fludarabine phosphate
4
fludarabine
4
Whole-Body Irradiation
4
Vincristine
4
CT-P10
4
polatuzumab vedotin
3
orelabrutinib
3
Mycophenolic Acid
3
Doxorubicin
3
Cyclosporine
3
Bendamustine Hydrochloride
3
pirtobrutinib
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Busulfan
2
voruciclib
1
treosulfan
1
tafasitamab
1
prednylidene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
CTLA-4 Antigen
×
90 days
×
Clear all
No trials found.